MARK4 inhibitor 3

Description: MAPK4 Inhibitor 3 (compound 23b) serves as a selective antagonist of MAPK4, demonstrating an inhibition constant (IC50) of 1.01 µM and effectively impeding the proliferation of cancer cells. This compound is utilized in research focused on cancer and tauopathies [1]. Target: Others. Smiles: CC1=CC=C2C(C(C(C=CC=C3)=C3N2CC(N[C@@H](CC4=CNC5=C4C=CC=C5)C(NC6=CC=C(F)C=C6)=O)=O)=O)=C1